Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vilzula M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Nivulia Lifesciences Private Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vilzula M 500mg/50mg Tablet

Metformin/Sitagliptin 500mg/50mg tablets manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may lessen the probability of cardiovascular events. It can be administered independently or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose readings, and current medications. Consuming it with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Effective blood sugar control helps prevent future health problems. Continued commitment to your doctor's recommended diet and exercise plan is crucial for managing your diabetes. Lifestyle choices significantly influence diabetes control. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this condition. This medication isn't appropriate for all patients. Inform your physician of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Drug interactions are possible; disclose all medications to ensure safe usage. Alcohol consumption should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout your treatment.

Primary Ingredients of Vilzula M 500mg/50mg Tablet

There is no text provided to rephrase.

Uses of Vilzula M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vilzula M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vilzula M 500mg/50mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with a meal.

Common Side effects of Vilzula M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vilzula M 500mg/50mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 500mg/50mg Vilzula M tablet whole; avoid crushing, chewing, or breaking it. Consume this medicine with a meal.

How Vilzula M 500mg/50mg Tablet works:

Each Vilzula M 500mg/50mg tablet contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Vilzula M 500mg/50mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vilzula M 500mg/50mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vilzula M 500mg/50mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Vilzula M 500mg/50mg tablets. Dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Use of Vilzula M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vilzula M 500mg/50mg Tablet :

Should you forget a Vilzula M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vilzula M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vilzula M 500mg/50mg Tablet

Vilzula M 500mg/50mg tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These are more likely if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vilzula M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Consult your doctor before taking any other medication.
Patients with known allergies to Vilzula M 500mg/50mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vilzula M 500mg/50mg tablets combine metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated in individuals under 18.
Vilzula M 500mg/50mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Vilzula M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Vilzula M 500mg/50mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Vilzula M 500mg/50mg Tablet as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Vilzula M 500mg/50mg Tabl...
62
MRP 72
14% off